ScholarIQanswers from OpenAlex
Merck Sharp and Dohme
FunderResearch funding and supported work
Merck Sharp and Dohme is a funder indexed in ScholarIQ from OpenAlex.
How many works does Merck Sharp and Dohme have?
ScholarIQindexed works
Merck Sharp and Dohme has 6,864 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Merck Sharp and Dohme?
ScholarIQopenalex
The OpenAlex for Merck Sharp and Dohme is on the source record.
What are the most-cited papers on Merck Sharp and Dohme?
ScholarIQmost cited works
Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes
Michael Offin, Joseph M. Chan, Megan Tenet, Hira Rizvi, Ronglai Shen, Gregory J. Riely, Natasha Rekhtman, Yahya Daneshbod, Àlvaro Quintanal-Villalonga, Alexander Penson, Matthew D. Hellmann, Maria E. Arcila, Marc Ladanyi, Dana Pe’er, Mark G. Kris, Charles M. Rudin, Helena A. Yu
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
Susana Banerjee, Kathleen N Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit Oza, Antonio González-Martín, Carol Aghajanian, William H Bradley, Eileen Holmes, Elizabeth S Lowe, Paul DiSilvestro
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups
Kenneth W. Mahaffey, Meg Jardine, Séverine Bompoint, Christopher P. Cannon, Bruce Neal, Hiddo J.L. Heerspink, David M. Charytan, Robert Edwards, Rajiv Agarwal, George L. Bakris, Scott Bull, George Capuano, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol A. Pollock, Tao Sun, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Norman Rosenthal, Barry M. Brenner, Vlado Perkovic, On behalf of the CREDENCE Study Investigators
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Eva Pros, Maria Saigí, Daniel Alameda, Gema Gómez‐Mariano, Beatriz Martínez–Delgado, Juan J. Alburquerque-Béjar, Julián Carretero, Raúl Tonda, Anna Esteve‐Codina, I. Català, Ramón Palmero, Maria Jové, Conxi Lázaro, Ana Patiño‐García, Ignacio Gil‐Bazo, Sara Verdura, Àlex Teulé, Juan Torres‐Lanzas, David Sidransky, Noemı́ Reguart, Rubén Pı́o, Óscar Juan, Ernest Nadal, Enriqueta Felip, Luis M. Montuenga, Montse Sánchez‐Céspedes
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial
Michael Friedländer, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Alla Lisyanskaya, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Joyce F. Liu, Cara Mathews, Frédèric Selle, Alain Lortholary, Elizabeth Lowe, Robert Hettle, Emuella Flood, Elena Parkhomenko, Paul DiSilvestro